JP2010514506A - 薬剤伝搬のモデリング - Google Patents
薬剤伝搬のモデリング Download PDFInfo
- Publication number
- JP2010514506A JP2010514506A JP2009544178A JP2009544178A JP2010514506A JP 2010514506 A JP2010514506 A JP 2010514506A JP 2009544178 A JP2009544178 A JP 2009544178A JP 2009544178 A JP2009544178 A JP 2009544178A JP 2010514506 A JP2010514506 A JP 2010514506A
- Authority
- JP
- Japan
- Prior art keywords
- patient
- injection
- contrast agent
- injector
- model
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 229940079593 drug Drugs 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 283
- 238000002347 injection Methods 0.000 claims abstract description 216
- 239000007924 injection Substances 0.000 claims abstract description 216
- 239000002872 contrast media Substances 0.000 claims abstract description 191
- 238000003384 imaging method Methods 0.000 claims abstract description 97
- 238000013178 mathematical model Methods 0.000 claims abstract description 80
- 238000001802 infusion Methods 0.000 claims abstract description 79
- 239000012530 fluid Substances 0.000 claims abstract description 75
- 230000004044 response Effects 0.000 claims abstract description 66
- 238000012546 transfer Methods 0.000 claims abstract description 64
- 230000000747 cardiac effect Effects 0.000 claims abstract description 41
- 230000002708 enhancing effect Effects 0.000 claims abstract description 35
- 238000005259 measurement Methods 0.000 claims abstract description 26
- 239000000243 solution Substances 0.000 claims abstract description 24
- 238000002059 diagnostic imaging Methods 0.000 claims abstract description 16
- 230000008569 process Effects 0.000 claims abstract description 16
- 238000012360 testing method Methods 0.000 claims description 82
- 230000006870 function Effects 0.000 claims description 67
- 238000011156 evaluation Methods 0.000 claims description 34
- 210000004369 blood Anatomy 0.000 claims description 30
- 239000008280 blood Substances 0.000 claims description 30
- 238000005457 optimization Methods 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
- 239000011780 sodium chloride Substances 0.000 claims description 20
- 210000000709 aorta Anatomy 0.000 claims description 17
- 230000003595 spectral effect Effects 0.000 claims description 17
- 210000001147 pulmonary artery Anatomy 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 210000002376 aorta thoracic Anatomy 0.000 claims description 8
- 230000002612 cardiopulmonary effect Effects 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 7
- 238000002604 ultrasonography Methods 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 5
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 4
- 230000001174 ascending effect Effects 0.000 claims description 4
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 4
- 230000002285 radioactive effect Effects 0.000 claims description 4
- 229910052724 xenon Inorganic materials 0.000 claims description 4
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 4
- 230000004872 arterial blood pressure Effects 0.000 claims description 3
- 230000005540 biological transmission Effects 0.000 claims description 3
- 238000004590 computer program Methods 0.000 claims description 3
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000002847 impedance measurement Methods 0.000 claims 1
- 238000002591 computed tomography Methods 0.000 description 46
- 238000013459 approach Methods 0.000 description 33
- 238000004422 calculation algorithm Methods 0.000 description 19
- 210000002216 heart Anatomy 0.000 description 15
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
- 210000004204 blood vessel Anatomy 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 230000001276 controlling effect Effects 0.000 description 12
- 210000003462 vein Anatomy 0.000 description 12
- 239000011159 matrix material Substances 0.000 description 11
- 230000035479 physiological effects, processes and functions Effects 0.000 description 10
- 230000003416 augmentation Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 238000010968 computed tomography angiography Methods 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 7
- 108090001061 Insulin Proteins 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 239000011630 iodine Substances 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000036470 plasma concentration Effects 0.000 description 7
- 241001123248 Arma Species 0.000 description 6
- 206010015866 Extravasation Diseases 0.000 description 6
- 230000036251 extravasation Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 238000002583 angiography Methods 0.000 description 5
- 230000002051 biphasic effect Effects 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 229940039231 contrast media Drugs 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000036765 blood level Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000013170 computed tomography imaging Methods 0.000 description 3
- 238000005094 computer simulation Methods 0.000 description 3
- 230000001934 delay Effects 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 238000012905 input function Methods 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 230000007310 pathophysiology Effects 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 210000005245 right atrium Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960001391 alfentanil Drugs 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 230000000876 cardiodynamic effect Effects 0.000 description 2
- 230000001364 causal effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000003193 general anesthetic agent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 238000002600 positron emission tomography Methods 0.000 description 2
- 230000004088 pulmonary circulation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 238000012897 Levenberg–Marquardt algorithm Methods 0.000 description 1
- 238000007476 Maximum Likelihood Methods 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000001601 blood-air barrier Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000037198 cardiovascular physiology Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- -1 chemotherapy Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960001089 dobutamine Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007446 glucose tolerance test Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000005032 impulse control Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003093 intracellular space Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000005405 multipole Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000005316 response function Methods 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001042 thoracic artery Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000007487 urography Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/507—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for determination of haemodynamic parameters, e.g. perfusion CT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/029—Measuring blood output from the heart, e.g. minute volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/58—Testing, adjusting or calibrating thereof
- A61B6/582—Calibration
- A61B6/583—Calibration using calibration phantoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0891—Clinical applications for diagnosis of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/13—Tomography
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Signal Processing (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87777606P | 2006-12-29 | 2006-12-29 | |
| PCT/US2007/087765 WO2008082937A2 (en) | 2006-12-29 | 2007-12-17 | Modeling of pharmaceutical propagation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010514506A true JP2010514506A (ja) | 2010-05-06 |
| JP2010514506A5 JP2010514506A5 (enExample) | 2014-02-13 |
Family
ID=39589173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009544178A Pending JP2010514506A (ja) | 2006-12-29 | 2007-12-17 | 薬剤伝搬のモデリング |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100030073A1 (enExample) |
| EP (1) | EP2097004A2 (enExample) |
| JP (1) | JP2010514506A (enExample) |
| WO (1) | WO2008082937A2 (enExample) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8396491B2 (en) | 2008-05-27 | 2013-03-12 | Ntt Docomo, Inc. | Location information management method and network device |
| JP2013533028A (ja) * | 2010-06-24 | 2013-08-22 | メドラッド、インク． | 注入プロトコルのための医薬品の伝播およびパラメータ生成のモデル |
| JP2015213633A (ja) * | 2014-05-12 | 2015-12-03 | 株式会社根本杏林堂 | 注入プロトコル設定装置、薬液注入装置および医療システム |
| US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
| JP2018079138A (ja) * | 2016-11-17 | 2018-05-24 | 株式会社根本杏林堂 | 注入プロトコルの生成装置、該生成装置を備える注入装置及び撮像システム、注入プロトコル生成方法、及び注入プロトコル生成プログラム |
| JP2020032246A (ja) * | 2019-11-13 | 2020-03-05 | 株式会社根本杏林堂 | 注入プロトコル設定装置、薬液注入装置および医療システム |
| JP2022078088A (ja) * | 2016-11-22 | 2022-05-24 | バイエル・ヘルスケア・エルエルシー | 造影剤を用いた合成磁気共鳴イメージングおよび磁気共鳴指紋法、ならびに造影剤注入プロトコルの決定 |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5232473B2 (ja) | 2004-11-24 | 2013-07-10 | メドラッド インコーポレーテッド | 注入処理中に生成される圧力をモデル化するためのシステム及び装置 |
| DE102006055167A1 (de) * | 2005-12-23 | 2007-07-05 | Siemens Ag | Betriebsverfahren für eine Röntgeneinrichtung zur Untersuchung eines Patienten unter Einsatz eines Kontrastmittels |
| DE102006032991B4 (de) * | 2006-07-17 | 2015-03-26 | Siemens Aktiengesellschaft | Verfahren und Rechnereinheit zur Einstellung einer Spritzenpumpe für eine Bildaufnahme |
| DK2097835T3 (en) | 2006-12-29 | 2018-09-03 | Bayer Healthcare Llc | PATIENT-BASED PARAMETER GENERATION SYSTEMS FOR MEDICAL INJECTION PROCEDURES |
| US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
| JP5534703B2 (ja) * | 2009-04-15 | 2014-07-02 | 株式会社東芝 | Ｘ線診断装置 |
| US8563919B2 (en) | 2010-05-28 | 2013-10-22 | University Health Network | Dynamic flow imaging phantom and model therefor |
| DE102012209410B4 (de) * | 2012-06-04 | 2020-08-13 | Siemens Healthcare Gmbh | Ermittlung einer patientenspezifischen Kontrastmittel-Impulsantwortfunktion sowie darauf basierende Vorhersage eines voraussichtlichen Kontrastmittelverlaufs und Ansteuerung eines medizintechnischen Bildgebungssystems |
| CN104519794B (zh) * | 2012-08-06 | 2018-05-22 | 皇家飞利浦有限公司 | 基于动态对比增强成像的渗透率度量 |
| DE102013201136B4 (de) | 2013-01-24 | 2023-01-19 | Siemens Healthcare Gmbh | Vorhersage eines voraussichtlichen Kontrastmittelverlaufs |
| CN103338225B (zh) * | 2013-05-27 | 2015-02-25 | 沈阳东软医疗系统有限公司 | 基于云平台的医疗影像数据共享的方法、云平台和系统 |
| CN104217398B (zh) * | 2013-05-29 | 2017-07-14 | 东芝医疗系统株式会社 | 图像处理装置、图像处理方法和医学图像设备 |
| NL2011470C2 (en) | 2013-09-19 | 2015-04-07 | Medicor Internat N V | Methods and tools relating to the administration of contrast medium. |
| US9456798B2 (en) * | 2014-05-12 | 2016-10-04 | The University Of Maryland, Baltimore | Methods and apparatus for individually optimizing uniform contrast enhancements in computed tomography imaging |
| WO2015179196A1 (en) * | 2014-05-19 | 2015-11-26 | Boston Medical Center Corporation | Aqueous contrast agents for dynamic mri and mra |
| CN104306010B (zh) * | 2014-09-17 | 2017-01-04 | 沈阳东软医疗系统有限公司 | 一种设置造影剂参数的方法、装置以及一种ct系统 |
| EP3458987A1 (en) | 2016-05-20 | 2019-03-27 | Bayer Healthcare LLC | Flexible, extensible and automated systems and methods for scoring the quality of radiology examinations |
| US10933186B2 (en) | 2016-11-22 | 2021-03-02 | Bayer Healthcare Llc | System and method for delivering a fluid with a consistent total volumetric flowrate |
| AU2018285887A1 (en) | 2017-06-16 | 2020-01-02 | Bayer Healthcare Llc | Systems and methods for split bolus protocol generation |
| US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
| US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| AU2019253676B2 (en) | 2018-04-10 | 2024-06-13 | Bayer Healthcare Llc | Preloading of contrast injection protocols into the administration line |
| WO2019199632A1 (en) | 2018-04-10 | 2019-10-17 | Bayer Healthcare Llc | System and method for testing blood vessel access using powered fluid injector systems |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| WO2020056418A1 (en) | 2018-09-14 | 2020-03-19 | Neuroenhancement Lab, LLC | System and method of improving sleep |
| US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
| US11569155B2 (en) | 2021-06-09 | 2023-01-31 | Western Digital Technologies, Inc. | Substrate bonding pad having a multi-surface trace interface |
| EP4362042A1 (en) * | 2022-10-31 | 2024-05-01 | Siemens Healthineers AG | Estimating pharmacokinetics of a contrast medium through a cardiovascular system analytical model and/or neural network algorithm |
| CN120393177B (zh) * | 2025-07-04 | 2025-08-29 | 天津市塑料研究所有限公司 | 一种血管造影高压注射系统 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006055813A2 (en) * | 2004-11-16 | 2006-05-26 | Medrad, Inc. | Modeling of pharmaceutical propagation |
Family Cites Families (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3701345A (en) * | 1970-09-29 | 1972-10-31 | Medrad Inc | Angiographic injector equipment |
| US3812843A (en) * | 1973-03-12 | 1974-05-28 | Lear Siegler Inc | Method and apparatus for injecting contrast media into the vascular system |
| US3898983A (en) * | 1973-10-03 | 1975-08-12 | James O Elam | Device and method for detecting the degree of muscle relaxation of a medical patient |
| US3888239A (en) * | 1974-06-21 | 1975-06-10 | Morton K Rubinstein | Fluid injection system |
| US4135247A (en) * | 1977-08-15 | 1979-01-16 | Siemens Aktiengesellschaft | Tomography signal processing system |
| US4151845A (en) * | 1977-11-25 | 1979-05-01 | Miles Laboratories, Inc. | Blood glucose control apparatus |
| US4207871A (en) * | 1978-06-07 | 1980-06-17 | Imed Corporation | System for controlling the flow of intravenous fluids to a patient |
| US4280494A (en) * | 1979-06-26 | 1981-07-28 | Cosgrove Robert J Jun | System for automatic feedback-controlled administration of drugs |
| US4319568A (en) * | 1979-10-29 | 1982-03-16 | Vickers Limited | Liquid dispensing apparatus |
| US4340153A (en) * | 1980-11-28 | 1982-07-20 | Spivey David L | Method and apparatus for medication dispensing |
| US4396385A (en) * | 1980-12-05 | 1983-08-02 | Baxter Travenol Laboratories, Inc. | Flow metering apparatus for a fluid infusion system |
| US4409966A (en) * | 1981-05-29 | 1983-10-18 | Lambrecht Richard M | Method and apparatus for injecting a substance into the bloodstream of a subject |
| US4392849A (en) * | 1981-07-27 | 1983-07-12 | The Cleveland Clinic Foundation | Infusion pump controller |
| US4444198A (en) * | 1981-12-21 | 1984-04-24 | Petre John H | Circulatory monitoring system and method |
| DE3203594A1 (de) * | 1982-02-03 | 1983-08-11 | Siemens AG, 1000 Berlin und 8000 München | Roentgendiagnostikanlage fuer angiographische roentgenaufnahmen |
| JPS58152542A (ja) * | 1982-03-05 | 1983-09-10 | 株式会社東芝 | Ｘ線診断装置 |
| US4515584A (en) * | 1982-07-06 | 1985-05-07 | Fujisawa Pharmaceutical Co., Ltd. | Artificial pancreas |
| US4479761A (en) * | 1982-12-28 | 1984-10-30 | Baxter Travenol Laboratories, Inc. | Actuator apparatus for a prepackaged fluid processing module having pump and valve elements operable in response to externally applied pressures |
| US4509526A (en) * | 1983-02-08 | 1985-04-09 | Lawrence Medical Systems, Inc. | Method and system for non-invasive ultrasound Doppler cardiac output measurement |
| US4585941A (en) * | 1983-02-28 | 1986-04-29 | E. R. Squibb & Sons, Inc. | Dosimetry system for strontium-rubidium infusion pump |
| JPS59214431A (ja) * | 1983-05-20 | 1984-12-04 | 株式会社東芝 | 放射線診断装置 |
| US4798590A (en) * | 1983-11-22 | 1989-01-17 | Medical Technology Products, Inc. | Intravenous infusion pumping system including independent pump set |
| NL8304397A (nl) * | 1983-12-22 | 1985-07-16 | Philips Nv | Roentgenonderzoekapparaat met beeldsubstractie. |
| US4854324A (en) * | 1984-01-31 | 1989-08-08 | Medrad, Inc. | Processor-controlled angiographic injector device |
| US4551133A (en) * | 1984-04-16 | 1985-11-05 | American Hospital Supply Corporation | Patient controlled medication infusion system |
| JPH0614746B2 (ja) * | 1984-09-13 | 1994-02-23 | 株式会社東芝 | Ｘ線画像処理装置 |
| JPS61115539A (ja) * | 1984-11-09 | 1986-06-03 | 株式会社 日立メデイコ | デイジタル型ｘ線撮影装置 |
| US4634426A (en) * | 1984-12-11 | 1987-01-06 | Baxter Travenol Laboratories | Medical infusion controller and user interface |
| US5088981A (en) * | 1985-01-18 | 1992-02-18 | Howson David C | Safety enhanced device and method for effecting application of a therapeutic agent |
| US4710166A (en) * | 1985-11-08 | 1987-12-01 | Quest Medical, Inc. | Automated drug additive infusion system |
| US4838856A (en) * | 1987-07-02 | 1989-06-13 | Truckee Meadows Research & Development | Fluid infusion flow control system |
| US4925444A (en) * | 1987-08-07 | 1990-05-15 | Baxter Travenol Laboratories, Inc. | Closed multi-fluid delivery system and method |
| US4880014A (en) * | 1987-08-14 | 1989-11-14 | Zarowitz Barbara J | Method for determining therapeutic drug dosage using bioelectrical resistance and reactance measurements |
| DE3739229A1 (de) * | 1987-11-19 | 1989-06-01 | Siemens Ag | Medizinische untersuchungsanlage |
| US5040537A (en) * | 1987-11-24 | 1991-08-20 | Hitachi, Ltd. | Method and apparatus for the measurement and medical treatment using an ultrasonic wave |
| US4874359A (en) * | 1987-12-14 | 1989-10-17 | White Frederick R | Power infuser |
| US4853521A (en) * | 1987-12-28 | 1989-08-01 | Claeys Ronald W | System for verifying and recording drug administration to a patient |
| GB8808305D0 (en) * | 1988-04-08 | 1988-05-11 | Nycomed As | Compositions |
| DE3817411A1 (de) * | 1988-05-21 | 1989-11-30 | Fresenius Ag | Mehrfachinfusionssystem |
| US4943279A (en) * | 1988-09-30 | 1990-07-24 | C. R. Bard, Inc. | Medical pump with infusion controlled by a detachable coded label |
| JPH02109546A (ja) * | 1988-10-18 | 1990-04-23 | Toshiba Corp | Ｘ線ｃｔ装置を用いた診断装置 |
| JP2781914B2 (ja) * | 1988-12-09 | 1998-07-30 | 日本アイデント・グラフ株式会社 | 連続立体撮影観察装置 |
| US5153827A (en) * | 1989-01-30 | 1992-10-06 | Omni-Flow, Inc. | An infusion management and pumping system having an alarm handling system |
| US5104374A (en) * | 1990-01-16 | 1992-04-14 | Bishko Jay R | Electronic fluid flow rate controller for controlling the infusion of intravenous drugs into a patient |
| US4995064A (en) * | 1990-01-29 | 1991-02-19 | Siemens Medical Systems, Inc. | Continuously sweeping multiple-pass image acquisition system for peripheral angiography |
| US5078683A (en) * | 1990-05-04 | 1992-01-07 | Block Medical, Inc. | Programmable infusion system |
| FR2664153B1 (fr) * | 1990-07-06 | 1992-09-11 | Gen Electric Cgr | Systeme de radiodiagnostic pour examen angiographique avec dispositif automatique de suivi d'embole. |
| IL95743A (en) * | 1990-09-19 | 1993-02-21 | Univ Ramot | Method of measuring blood flow |
| US5180896A (en) * | 1990-10-11 | 1993-01-19 | University Of Florida | System and method for in-line heating of medical fluid |
| US5339799A (en) * | 1991-04-23 | 1994-08-23 | Olympus Optical Co., Ltd. | Medical system for reproducing a state of contact of the treatment section in the operation unit |
| US5300031A (en) * | 1991-06-07 | 1994-04-05 | Liebel-Flarsheim Company | Apparatus for injecting fluid into animals and disposable front loadable syringe therefor |
| DE4218321A1 (de) * | 1991-12-09 | 1993-06-17 | Siemens Ag | Diagnostikanlage |
| AU3329793A (en) * | 1991-12-20 | 1993-07-28 | Abbott Laboratories | Infusion pump security system |
| WO1993012825A1 (en) * | 1991-12-20 | 1993-07-08 | Abbott Laboratories | Automated drug infusion system with autopriming |
| JPH05290317A (ja) * | 1992-04-13 | 1993-11-05 | Mitsubishi Electric Corp | 磁気ヘッドおよびその製造方法 |
| US5382232A (en) * | 1992-03-13 | 1995-01-17 | Ivac Corporation | Infusion system with air-in-line clear function |
| DE4210120C1 (en) * | 1992-03-27 | 1993-08-05 | Siemens Ag, 8000 Muenchen, De | X=ray appts. for peripheral angiography - calculates relative positioning of appts. and patient support using data derived from patient |
| US5361761A (en) * | 1992-06-17 | 1994-11-08 | Wisconsin Alumni Research Foundation | Method and apparatus for measuring blood iodine concentration |
| JP2636504B2 (ja) * | 1992-07-27 | 1997-07-30 | シュナイダー・（ユーエスエイ）・インコーポレーテッド | 注入内腔を有する拡大カテーテル |
| US5383858B1 (en) * | 1992-08-17 | 1996-10-29 | Medrad Inc | Front-loading medical injector and syringe for use therewith |
| US5338662A (en) * | 1992-09-21 | 1994-08-16 | Bio-Preserve Medical Corporation | Organ perfusion device |
| GB9225014D0 (en) * | 1992-11-30 | 1993-01-20 | Univ Hospital London Dev Corp | Pulse injector for quantitative angiographic blood-flow measurements |
| US5472403A (en) * | 1993-05-11 | 1995-12-05 | The Regents Of The University Of California | Device for automatic injection of radionuclide |
| US5385540A (en) * | 1993-05-26 | 1995-01-31 | Quest Medical, Inc. | Cardioplegia delivery system |
| US5579767A (en) * | 1993-06-07 | 1996-12-03 | Prince; Martin R. | Method for imaging abdominal aorta and aortic aneurysms |
| US5590654A (en) * | 1993-06-07 | 1997-01-07 | Prince; Martin R. | Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| US5417213A (en) * | 1993-06-07 | 1995-05-23 | Prince; Martin R. | Magnetic resonance arteriography with dynamic intravenous contrast agents |
| US5469849A (en) * | 1993-06-14 | 1995-11-28 | Kabushiki Kaisha Toshiba | Ultrasound diagnosis apparatus |
| DE4320365C2 (de) * | 1993-06-19 | 2000-07-13 | Uvo Hoelscher | Mehrkanal-Dosiersystem |
| US5456255A (en) * | 1993-07-12 | 1995-10-10 | Kabushiki Kaisha Toshiba | Ultrasonic diagnosis apparatus |
| FR2708166A1 (fr) * | 1993-07-22 | 1995-01-27 | Philips Laboratoire Electroniq | Procédé de traitement d'images numérisées pour la détection automatique de sténoses. |
| US5368562A (en) * | 1993-07-30 | 1994-11-29 | Pharmacia Deltec, Inc. | Systems and methods for operating ambulatory medical devices such as drug delivery devices |
| DE69432582T2 (de) * | 1993-10-28 | 2003-11-27 | Medrad, Inc. | System zur Administration von Flüssigkeiten bei mehreren Patienten |
| US5569181A (en) * | 1993-10-28 | 1996-10-29 | Medrad, Inc. | Sterility assurance for contrast delivery system |
| US5494036A (en) * | 1993-11-26 | 1996-02-27 | Medrad, Inc. | Patient infusion system for use with MRI |
| US5566092A (en) * | 1993-12-30 | 1996-10-15 | Caterpillar Inc. | Machine fault diagnostics system and method |
| US5531679A (en) * | 1994-03-14 | 1996-07-02 | Schulman; Joseph H. | Fluidic infusion system for catheter or probe |
| US5881124A (en) * | 1994-03-31 | 1999-03-09 | Arch Development Corporation | Automated method and system for the detection of lesions in medical computed tomographic scans |
| US5458128A (en) * | 1994-06-17 | 1995-10-17 | Polanyi; Michael | Method and apparatus for noninvasively measuring concentration of a dye in arterial blood |
| EP0692766B1 (en) * | 1994-07-12 | 2002-05-08 | Medrad, Inc. | Closed loop information path for medical fluid delivery systems |
| US5840026A (en) * | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
| US5522798A (en) * | 1994-10-17 | 1996-06-04 | Abbott Laboratories | Control of a multi-channel drug infusion pump using a pharmacokinetic model |
| US5459769A (en) * | 1994-11-09 | 1995-10-17 | General Electric Company | Procedure for monitoring contrast agent application in a CT imaging system |
| US5724976A (en) * | 1994-12-28 | 1998-03-10 | Kabushiki Kaisha Toshiba | Ultrasound imaging preferable to ultrasound contrast echography |
| US5573515A (en) * | 1995-04-20 | 1996-11-12 | Invasatec, Inc. | Self purging angiographic injector |
| US5743266A (en) * | 1995-04-25 | 1998-04-28 | Molecular Biosystems, Inc. | Method for processing real-time contrast enhanced ultrasonic images |
| US5902525A (en) * | 1995-06-19 | 1999-05-11 | Hettinga; Siebolt | Method of molding a plastic article including injecting based upon a pressure-dominated control algorithm after detecting an indicia of a decrease in the surface area of the melt front |
| US5687208A (en) * | 1995-10-06 | 1997-11-11 | Bhb General Partnership | Method of and apparatus for predicting computed tomography contrast enhancement with feedback |
| US5583902A (en) * | 1995-10-06 | 1996-12-10 | Bhb General Partnership | Method of and apparatus for predicting computed tomography contrast enhancement |
| US5713358A (en) * | 1996-03-26 | 1998-02-03 | Wisconsin Alumni Research Foundation | Method for producing a time-resolved series of 3D magnetic resonance angiograms during the first passage of contrast agent |
| WO1997040468A1 (en) * | 1996-04-24 | 1997-10-30 | Shriners Hospitals For Children | Method and apparatus for recording three-dimensional topographies |
| US5796862A (en) * | 1996-08-16 | 1998-08-18 | Eastman Kodak Company | Apparatus and method for identification of tissue regions in digital mammographic images |
| US5865744A (en) * | 1996-09-16 | 1999-02-02 | Lemelson; Jerome H. | Method and system for delivering therapeutic agents |
| US6236706B1 (en) * | 1996-12-12 | 2001-05-22 | General Electric Company | Methods and apparatus for predicting contrast agent uptake in a computed tomography system |
| US6073042A (en) * | 1997-09-25 | 2000-06-06 | Siemens Medical Systems, Inc. | Display of three-dimensional MRA images in which arteries can be distinguished from veins |
| US6055985A (en) * | 1999-04-09 | 2000-05-02 | B.H.B., L.C. | Methods for injecting a contrast medium to generate prolonged uniform vascular enhancement |
-
2007
- 2007-12-17 JP JP2009544178A patent/JP2010514506A/ja active Pending
- 2007-12-17 US US12/519,040 patent/US20100030073A1/en not_active Abandoned
- 2007-12-17 EP EP07855213A patent/EP2097004A2/en not_active Withdrawn
- 2007-12-17 WO PCT/US2007/087765 patent/WO2008082937A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006055813A2 (en) * | 2004-11-16 | 2006-05-26 | Medrad, Inc. | Modeling of pharmaceutical propagation |
| JP2008520287A (ja) * | 2004-11-16 | 2008-06-19 | メドラッド インコーポレーテッド | 薬剤注入に対する患者搬送関数を決定し、患者反応をモデル化するシステム及び方法 |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8396491B2 (en) | 2008-05-27 | 2013-03-12 | Ntt Docomo, Inc. | Location information management method and network device |
| JP2013533028A (ja) * | 2010-06-24 | 2013-08-22 | メドラッド、インク． | 注入プロトコルのための医薬品の伝播およびパラメータ生成のモデル |
| JP2016152940A (ja) * | 2010-06-24 | 2016-08-25 | ベイヤー メディカル ケア インク． | 注入プロトコルのための医薬品の伝播およびパラメータ生成のモデル |
| US9959389B2 (en) | 2010-06-24 | 2018-05-01 | Bayer Healthcare Llc | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
| US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
| JP2015213633A (ja) * | 2014-05-12 | 2015-12-03 | 株式会社根本杏林堂 | 注入プロトコル設定装置、薬液注入装置および医療システム |
| JP2018079138A (ja) * | 2016-11-17 | 2018-05-24 | 株式会社根本杏林堂 | 注入プロトコルの生成装置、該生成装置を備える注入装置及び撮像システム、注入プロトコル生成方法、及び注入プロトコル生成プログラム |
| JP2022078088A (ja) * | 2016-11-22 | 2022-05-24 | バイエル・ヘルスケア・エルエルシー | 造影剤を用いた合成磁気共鳴イメージングおよび磁気共鳴指紋法、ならびに造影剤注入プロトコルの決定 |
| JP7315735B2 (ja) | 2016-11-22 | 2023-07-26 | バイエル・ヘルスケア・エルエルシー | 造影剤を用いた合成磁気共鳴イメージングおよび磁気共鳴指紋法、ならびに造影剤注入プロトコルの決定 |
| JP2020032246A (ja) * | 2019-11-13 | 2020-03-05 | 株式会社根本杏林堂 | 注入プロトコル設定装置、薬液注入装置および医療システム |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2097004A2 (en) | 2009-09-09 |
| WO2008082937A2 (en) | 2008-07-10 |
| US20100030073A1 (en) | 2010-02-04 |
| WO2008082937A3 (en) | 2008-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5780883B2 (ja) | 患者中にて薬液の伝搬をモデル化するシステム | |
| JP2010514506A (ja) | 薬剤伝搬のモデリング | |
| EP2170165B1 (en) | Systems for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery | |
| RU2600892C2 (ru) | Моделирование распространения фармацевтического препарата и генерирование параметров для инъекционных протоколов | |
| US20220133982A1 (en) | System and methods for delivering a test bolus for medical imaging | |
| JP2022078088A (ja) | 造影剤を用いた合成磁気共鳴イメージングおよび磁気共鳴指紋法、ならびに造影剤注入プロトコルの決定 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101206 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101206 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120904 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121120 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121128 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130128 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130204 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20130304 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130924 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20131217 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140624 |